WHO recommends malaria vaccine for kids in high-risk areas
The World Health Organization (WHO) today recommended the RTS,S malaria vaccine for children in sub-Saharan Africa and other areas of moderate and high Plasmodium falciparum malaria transmission. The recommendation paves the way for global health groups to make funding and vaccine rollout plans and for countries to decide whether to include vaccination in their malaria control programs.
Malaria is a leading cause of childhood illness and death in sub-Saharan Africa, and the WHO said more than 260,000 African children younger than 5 die from malaria each year. In a statement, WHO Director General Tedros Adhanom Ghebreyesus, PhD, said, "This is a historic moment. The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control."
The WHO based its recommendation on advice from two of its advisory groups, one on vaccines and the other on malaria, following promising vaccine pilot programs in Malawi, Kenya, and Ghana. The RTS,S vaccine is given on a four-dose schedule that begins at 5 months of age and continues through age 2.
The vaccine, from GlaxoSmithKline, has been 30 years in the making.
Oct 6 WHO statement
Study finds C difficile is prevalent outside of healthcare settings
A study presented last week at IDWeek 2021 suggests Clostridiodes difficile is more prevalent outside of the hospital than previously thought. And the soles of people's shoes may play a significant role in spread of the bacterium.
Researchers at the University of Houston analyzed environmental samples collected from public areas, healthcare settings, and shoe soles in 11 countries from 2014 through 2017 for the presence of C difficile, which causes severe diarrhea and is the leading cause of hospital-associated infections but is increasingly being reported in community settings. The aim was to examine the prevalence and the strain types of the bacterium in different settings.
Of the 11,986 unique isolates collected, 92% were from the United States, 1.7% were from Taiwan, and 1.6% were from India. Samples were categorized as being from outdoor environments (2,992 isolates), private residences (2,772), shoe soles (1,420), public buildings (1,104), and acute care settings (3,698). Worldwide C difficile sample positivity was 26% and was similar between US and non-US sampling sites.
In the United States, private residences (26.2%) and outdoor environments (24.1%) had the highest positivity rate compared with public buildings (17.2%). In a sub-analysis of 8,571 isolates collected in Texas, positivity rates were highest in outdoor samples (27%) and were similar between private residences (24%) and healthcare buildings (24%). The most prevalent C difficile ribotypes (RTs) overall were F014-020 (16.4%), F106 (14.9%), and FP310 (11%). Shoe soles had the highest positivity rate (45%), with similar RT distribution between shoe soles and environmental samples.
"The results of this study shift our understanding of C. diff, including where it is found, how it is transmitted, and who it affects," co-author Kevin Garey, PharmD, of the University of Houston College of Pharmacy, said in an IDWeek press release. "We can no longer think of C. diff as only existing in healthcare settings, and the population at risk is no longer just the very sick patient in the hospital. Identifying that person at risk anywhere in the world should become a priority regardless of whether the person is in a hospital or the community."
The study authors said removing shoes before entering a home or a common space could help reduce community spread.
Sep 30 IDWeek press release
APHIS announces $5.7 million in support for CWD programs
The US Department of Agriculture Animal and Plant Health Inspection Service (APHIS) recently announced $5.7 million in support for chronic wasting disease (CWD) management and response activities targeting wild and farmed cervids in 20 states, as well as in 8 tribes or tribal organizations.
Kevin Shea, JD, APHIS administrator, said in a press release, "These collaborative efforts will strengthen our ability to find and implement new solutions as part of our mission to safeguard agriculture and natural resources." APHIS said priority areas included improving management of affected farmed herds and wild cervid populations, improved management of affected area or premises, research on testing technology, and developing and conducting educational outreach.
The group received 64 proposals, and scientific and program panels worked with submitters to refine the scope of promising projects when needed.
In documents that detailed the breakdown of the funding, APHIS said about $2.5 million went to wild cervid management, $1.5 million to farmed cervid management, $1.22 million to farmed cervid research, and $300,000 to tribal wild cervid management.
CWD, a deadly prion disease that affects cervids, was first identified in North America in 1967 and has spread across much of the United States and Canada. No human CWD cases have been confirmed, but some experts fear that eating meat from CWD-affected animals could trigger an illness similar to bovine spongiform encephalopathy (mad cow disease), also caused by prions.
Oct 1 APHIS press release
MERS sickens Saudi man
Saudi Arabia's Ministry of Health (MOH) reported another MERS-CoV case—its 13th of the year.
Like the last three cases, the patient is from Riyadh and had contact with camels, according to an MOH statement. The 58-year-old man's illness is considered primary, meaning he isn't thought to have contracted the MERS-CoV (Middle East respiratory syndrome coronavirus) from another sick person.
In a mid-August update, the WHO said that, since 2012, it had received reports of 2,578 lab-confirmed MERS cases around the world, including at least 888 deaths. The vast majority are from Saudi Arabia.
Sep 29 Saudi MOH statement
Aug 17 WHO update